فهرست نشریات علمی دسترسی آزاد ایران

Background: Medications, alternative and complementary treatments for type-III chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) are used frequently. The aim of this article is to define thermobalancing therapy as an independent treatment for internal diseases, such as CP/CPPS. Methods: The effect of thermobalancing therapy (TT) by using Dr. Allen’s therapeutic device-(DATD) on patients with CP/CPPS was investigated. National institute of health chronic prostatitis symptom index (NIH-CPSI) scores, prostatic volume (PV), and maximum urinary flow rate (Q max ) were measured in one group of 45 patients who underwent TT and a control group that did not have TT. These all parameters were compared between groups. Results: No significant difference was found at baseline evaluation in treatment and control groups with regard to age, NIH-CPSI score, PV or Q max . In the treatment group pain score decreased and quality of life (QoL) improved significantly, whereas in the control group no changes. TT reduced PV and increased Q max significantly, whereas in the control group TT did not elicit significant changes in PV and Q max . Conclusions: The study has explored that TT with DATD as monotherapy for CP/CPPS patients: (i) reduces pain dramatically and improves QoL; (ii) reduces PV and increases Q max . None of the patients who received TT suffered side effects and the cost of TT compares favourably with the cost of conventional treatment. Thus, TT could be recommended as a new independent treatment for CP/CPPS.